In February, the official representative of the WHO, Dr. Ute Rosskopf, responsible for interaction with laboratories, regulatory activities and safety, confirmed the full compliance of the influenza vaccine produced by the IICVSSP with world quality standards . "The WHO testing result supports the acceptability of the fractionated inactivated influenza vaccine produced by IICVSSP, Russian Federation, for prequalification," the statement said.
Prequalification is a service provided by WHO to assess the quality, safety and efficacy of medicines. Together with IICVSSP, the MECHNIKOV Institute plans to receive prequalification of its vaccine in 2021. Prequalification by the WHO is a crucial condition for the access of the drug to markets worldwide.
WHO Test report - Download
WHO Letter - Download